Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Growth Outlook: Why Analysts Expect Continued Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size, Value And Growth Trajectory Through 2030
The market size for benign prostatic hyperplasia (bph) treatment devices and equipment has demonstrated strong growth in recent years. It is anticipated to expand from $1.34 billion in 2025 to $1.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to factors such as the increasing prevalence of benign prostatic hyperplasia, heightened awareness of urological disorders, the adoption of transurethral procedures, the expansion of hospital urology departments, and improvements in endoscopic surgical tools.
The benign prostatic hyperplasia (bph) treatment devices and equipment market is expected to experience substantial growth over the next few years, with its size projected to reach $1.86 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth can be attributed to an expanding aging male population, a rising preference for minimally invasive therapies, the proliferation of outpatient urology clinics, increasing adoption of laser and implant-based treatments, and a greater emphasis on reducing hospital stays. Key trends for the forecast period include the increasing uptake of minimally invasive bph treatment devices, a growing utilization of laser-based prostate therapies, a heightened demand for implant-based treatment options, the expansion of office-based bph procedures, and an enhanced focus on patient comfort and recovery.
Get A Free Sample Report With In-Depth Market Insights:
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Growth Drivers: What’s Behind The Acceleration?
A rise in prostate cancer diagnoses is expected to propel the expansion of the benign prostatic hyperplasia market. This malignancy originates in the prostate gland, a small, walnut-shaped organ situated just beneath the bladder in males. More frequent occurrences of prostate cancer often prompt an increased number of older males to seek medical consultation for prostate-related concerns. This, in turn, facilitates the detection and treatment of benign prostatic hyperplasia. For example, data from February 2023, released by the American Society of Clinical Oncology (ASCO), a US-based professional body providing patient information via the cancer.net website, indicated approximately 288,300 men in the United States had prostate cancer in 2023. Additionally, 268,490 new cases and 34,500 fatalities were attributed to prostate cancer in 2022. Consequently, the rising incidence of prostate cancer is acting as a catalyst for the expansion of the benign prostatic hyperplasia market.
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Segments: Where Is Growth Concentrated?
The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Specialty Urology Centers
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends: What’s Defining The Industry’s Next Phase?
Key players in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are concentrating on creating innovative, minimally invasive options, including temporary implants, to increase access to outpatient care and lessen dependence on ongoing medication or tissue removal surgeries. These temporarily implantable BPH devices are either single-use or short-duration implants, engineered to reshape the prostatic urethra and alleviate lower urinary tract symptoms (LUTS) resulting from an enlarged prostate. As an illustration, in February 2025, Olympus, a Japan-based medical technology firm, reported a significant development for its iTind device, expanding its presence across key APAC markets (Thailand, Australia, Hong Kong, Singapore, India, with a forthcoming launch in Korea). They emphasized that the iTind procedure offers a minimally invasive, clinic-based choice achievable with local anaesthesia, bolstered by an extensive physician training program to facilitate its clinical integration. The iTind itself is a temporarily implantable nitinol device that works by reshaping the prostatic urethra, thereby enhancing urinary flow and improving patients’ quality of life, with recent advancements in guidelines and reimbursement aiding its faster acceptance.
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Leading Companies And Competitive Benchmarking
Major companies operating in the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System
View The Full Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Top Region By Revenue And Market Share
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2025. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
